| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lung Neoplasms | 17 | 2018 | 3228 | 2.91 | Why? |
| Carcinoma, Non-Small-Cell Lung | 5 | 2018 | 896 | 1.33 | Why? |
| Small Cell Lung Carcinoma | 2 | 2018 | 133 | 1.24 | Why? |
| Polynucleotide Adenylyltransferase | 2 | 2017 | 7 | 1.24 | Why? |
| Serum Albumin | 2 | 2018 | 571 | 1.06 | Why? |
| RNA, Long Noncoding | 2 | 2018 | 408 | 1.00 | Why? |
| Badnavirus | 1 | 2018 | 1 | 0.76 | Why? |
| Acrylamides | 1 | 2018 | 40 | 0.76 | Why? |
| Electroacupuncture | 1 | 2017 | 12 | 0.72 | Why? |
| Confined Spaces | 1 | 2018 | 37 | 0.72 | Why? |
| Eukaryotic Initiation Factor-4A | 1 | 2017 | 16 | 0.72 | Why? |
| Tuberculosis | 4 | 2018 | 2895 | 0.72 | Why? |
| Aniline Compounds | 1 | 2018 | 120 | 0.71 | Why? |
| Fabaceae | 1 | 2018 | 39 | 0.71 | Why? |
| Keratin-6 | 1 | 2017 | 1 | 0.71 | Why? |
| Mycobacterium tuberculosis | 2 | 2018 | 1164 | 0.71 | Why? |
| Viscera | 1 | 2017 | 38 | 0.71 | Why? |
| Transcutaneous Electric Nerve Stimulation | 1 | 2017 | 15 | 0.71 | Why? |
| Keratin-5 | 1 | 2017 | 46 | 0.70 | Why? |
| Acetic Acid | 1 | 2017 | 50 | 0.70 | Why? |
| Keratin-19 | 1 | 2017 | 16 | 0.69 | Why? |
| Aspartic Acid Endopeptidases | 1 | 2017 | 57 | 0.69 | Why? |
| PTEN Phosphohydrolase | 1 | 2017 | 70 | 0.69 | Why? |
| Hyperalgesia | 1 | 2017 | 61 | 0.68 | Why? |
| Antineoplastic Agents | 7 | 2018 | 3550 | 0.67 | Why? |
| Phosphopyruvate Hydratase | 1 | 2017 | 47 | 0.66 | Why? |
| Biomarkers, Tumor | 4 | 2018 | 1314 | 0.64 | Why? |
| Adenocarcinoma | 3 | 2018 | 651 | 0.64 | Why? |
| Mediastinal Neoplasms | 1 | 2017 | 57 | 0.63 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.62 | Why? |
| Tumor Suppressor Proteins | 1 | 2017 | 165 | 0.62 | Why? |
| Carcinoembryonic Antigen | 1 | 2017 | 140 | 0.61 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2021 | 436 | 0.60 | Why? |
| Hyperlipidemias | 1 | 2018 | 290 | 0.60 | Why? |
| Urea | 1 | 2017 | 228 | 0.59 | Why? |
| Lymphatic Metastasis | 2 | 2017 | 537 | 0.59 | Why? |
| Antigens, Neoplasm | 1 | 2017 | 230 | 0.58 | Why? |
| Transcription Factors | 2 | 2017 | 784 | 0.56 | Why? |
| B7-H1 Antigen | 1 | 2018 | 541 | 0.55 | Why? |
| Cell Nucleus | 2 | 2017 | 399 | 0.55 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.53 | Why? |
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2012 | 10 | 0.52 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2018 | 724 | 0.51 | Why? |
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2012 | 49 | 0.49 | Why? |
| Umbilical Cord | 1 | 2015 | 358 | 0.48 | Why? |
| Drug Resistance, Neoplasm | 5 | 2018 | 447 | 0.47 | Why? |
| Toll-Like Receptor 3 | 1 | 2015 | 391 | 0.47 | Why? |
| Toll-Like Receptor 4 | 1 | 2015 | 390 | 0.45 | Why? |
| Patients | 1 | 2019 | 1167 | 0.43 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2017 | 665 | 0.43 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.38 | Why? |
| Diagnostic Imaging | 1 | 2017 | 1044 | 0.38 | Why? |
| Signal Transduction | 5 | 2018 | 7207 | 0.37 | Why? |
| Drugs, Chinese Herbal | 3 | 2021 | 2760 | 0.37 | Why? |
| Artificial Intelligence | 2 | 2021 | 3543 | 0.37 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.36 | Why? |
| Stress, Physiological | 1 | 2012 | 378 | 0.36 | Why? |
| Quality of Health Care | 2 | 2020 | 1948 | 0.35 | Why? |
| Lymphocytes | 2 | 2017 | 3056 | 0.34 | Why? |
| Gene Expression Regulation | 2 | 2017 | 4020 | 0.33 | Why? |
| Neoplasm Staging | 4 | 2017 | 1999 | 0.32 | Why? |
| Rats, Sprague-Dawley | 3 | 2021 | 987 | 0.32 | Why? |
| C-Reactive Protein | 3 | 2020 | 7972 | 0.31 | Why? |
| Genetic Variation | 2 | 2018 | 3919 | 0.31 | Why? |
| Isoenzymes | 2 | 2017 | 127 | 0.29 | Why? |
| Early Detection of Cancer | 1 | 2017 | 1956 | 0.29 | Why? |
| Nucleotidyltransferases | 2 | 2017 | 77 | 0.28 | Why? |
| China | 17 | 2021 | 50654 | 0.27 | Why? |
| Molecular Epidemiology | 3 | 2021 | 1638 | 0.26 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.25 | Why? |
| Mutation | 4 | 2018 | 12376 | 0.24 | Why? |
| Disease Models, Animal | 5 | 2021 | 10998 | 0.23 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.22 | Why? |
| L-Lactate Dehydrogenase | 2 | 2020 | 1995 | 0.21 | Why? |
| Muscle, Skeletal | 2 | 2018 | 915 | 0.21 | Why? |
| Primary Health Care | 1 | 2019 | 4839 | 0.21 | Why? |
| Humans | 54 | 2021 | 930598 | 0.19 | Why? |
| Physicians | 1 | 2019 | 4214 | 0.19 | Why? |
| Mutant Chimeric Proteins | 1 | 2018 | 3 | 0.19 | Why? |
| Adenylate Kinase | 1 | 2018 | 13 | 0.19 | Why? |
| Claudins | 1 | 2018 | 22 | 0.19 | Why? |
| Arthritis, Experimental | 1 | 2019 | 44 | 0.19 | Why? |
| Carcinoma, Signet Ring Cell | 1 | 2018 | 12 | 0.19 | Why? |
| Maximum Tolerated Dose | 1 | 2018 | 65 | 0.19 | Why? |
| Desert Climate | 1 | 2018 | 10 | 0.19 | Why? |
| GTPase-Activating Proteins | 1 | 2018 | 36 | 0.19 | Why? |
| Male | 33 | 2021 | 367725 | 0.19 | Why? |
| Cluster Analysis | 2 | 2017 | 3001 | 0.19 | Why? |
| Bronchoscopy | 2 | 2017 | 991 | 0.19 | Why? |
| Ilarvirus | 1 | 2017 | 1 | 0.19 | Why? |
| Cucumis sativus | 1 | 2017 | 4 | 0.19 | Why? |
| Tubulin | 1 | 2018 | 67 | 0.18 | Why? |
| Cross-Priming | 1 | 2017 | 9 | 0.18 | Why? |
| Minisatellite Repeats | 1 | 2018 | 53 | 0.18 | Why? |
| Coumarins | 1 | 2018 | 46 | 0.18 | Why? |
| Protein Kinase Inhibitors | 2 | 2019 | 1585 | 0.18 | Why? |
| Genes, Plant | 1 | 2018 | 42 | 0.18 | Why? |
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 15 | 0.18 | Why? |
| Polyadenylation | 1 | 2017 | 21 | 0.18 | Why? |
| Carcinoma, Squamous Cell | 2 | 2017 | 902 | 0.18 | Why? |
| 5-Methylcytosine | 1 | 2017 | 16 | 0.18 | Why? |
| Polyamines | 1 | 2017 | 44 | 0.18 | Why? |
| Prognosis | 9 | 2020 | 32490 | 0.18 | Why? |
| Pulmonary Embolism | 1 | 2017 | 4775 | 0.18 | Why? |
| Nucleosomes | 1 | 2017 | 48 | 0.18 | Why? |
| Amines | 1 | 2017 | 67 | 0.18 | Why? |
| Retrospective Studies | 15 | 2021 | 105322 | 0.18 | Why? |
| Arabidopsis Proteins | 1 | 2017 | 54 | 0.17 | Why? |
| Silymarin | 1 | 2017 | 17 | 0.17 | Why? |
| Lignans | 1 | 2017 | 41 | 0.17 | Why? |
| Circulating Tumor DNA | 1 | 2017 | 46 | 0.17 | Why? |
| Natural Science Disciplines | 1 | 2017 | 15 | 0.17 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.17 | Why? |
| Gene Expression Regulation, Plant | 1 | 2017 | 110 | 0.17 | Why? |
| Arabidopsis | 1 | 2017 | 88 | 0.17 | Why? |
| Plant Diseases | 1 | 2018 | 84 | 0.17 | Why? |
| Lactic Acid | 1 | 2020 | 393 | 0.17 | Why? |
| Rats | 4 | 2021 | 2764 | 0.17 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.17 | Why? |
| Tubulin Modulators | 1 | 2018 | 126 | 0.17 | Why? |
| Cough | 3 | 2021 | 4891 | 0.16 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.16 | Why? |
| HSP90 Heat-Shock Proteins | 1 | 2017 | 98 | 0.16 | Why? |
| Tachypnea | 1 | 2017 | 197 | 0.16 | Why? |
| Neoplasm Metastasis | 2 | 2017 | 682 | 0.16 | Why? |
| Random Allocation | 2 | 2018 | 773 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Female | 29 | 2021 | 380317 | 0.16 | Why? |
| Mediastinum | 1 | 2017 | 122 | 0.16 | Why? |
| Quinazolines | 1 | 2017 | 126 | 0.16 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.16 | Why? |
| Cisplatin | 1 | 2017 | 209 | 0.16 | Why? |
| Biphenyl Compounds | 1 | 2017 | 249 | 0.15 | Why? |
| Pyrroles | 1 | 2019 | 292 | 0.15 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.15 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.15 | Why? |
| Radio Waves | 1 | 2015 | 27 | 0.15 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.15 | Why? |
| Cell Self Renewal | 1 | 2015 | 55 | 0.15 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2017 | 253 | 0.14 | Why? |
| Myocytes, Cardiac | 2 | 2017 | 804 | 0.14 | Why? |
| Creatine Kinase | 1 | 2017 | 386 | 0.14 | Why? |
| Principal Component Analysis | 1 | 2017 | 689 | 0.14 | Why? |
| Angiotensin I | 1 | 2017 | 200 | 0.14 | Why? |
| Microbiology | 1 | 2017 | 134 | 0.14 | Why? |
| Osteoblasts | 1 | 2015 | 87 | 0.14 | Why? |
| Histones | 1 | 2017 | 371 | 0.14 | Why? |
| Plasmids | 1 | 2018 | 840 | 0.14 | Why? |
| Apoptosis | 3 | 2018 | 2335 | 0.14 | Why? |
| Troponin T | 1 | 2020 | 771 | 0.14 | Why? |
| Cell-Free Nucleic Acids | 1 | 2017 | 271 | 0.14 | Why? |
| Reverse Transcription | 1 | 2017 | 673 | 0.14 | Why? |
| Dose-Response Relationship, Drug | 3 | 2019 | 3776 | 0.13 | Why? |
| Sirolimus | 1 | 2016 | 240 | 0.13 | Why? |
| Bone Neoplasms | 1 | 2017 | 287 | 0.13 | Why? |
| Cholesterol | 1 | 2018 | 660 | 0.13 | Why? |
| Cholestasis | 1 | 2015 | 114 | 0.13 | Why? |
| Airway Extubation | 1 | 2018 | 403 | 0.13 | Why? |
| Anti-Asthmatic Agents | 1 | 2018 | 427 | 0.12 | Why? |
| Health Care Reform | 1 | 2019 | 409 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| Survival Rate | 2 | 2017 | 9206 | 0.12 | Why? |
| Cell Communication | 1 | 2015 | 396 | 0.12 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.12 | Why? |
| Aged | 16 | 2021 | 215776 | 0.12 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.12 | Why? |
| Biological Evolution | 1 | 2018 | 641 | 0.12 | Why? |
| Bile Duct Neoplasms | 1 | 2015 | 172 | 0.12 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.12 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 581 | 0.12 | Why? |
| Geography | 1 | 2018 | 1801 | 0.11 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.11 | Why? |
| 3' Untranslated Regions | 1 | 2012 | 318 | 0.11 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.11 | Why? |
| RNA Stability | 1 | 2012 | 285 | 0.11 | Why? |
| Pyrimidines | 1 | 2019 | 1557 | 0.11 | Why? |
| Immunohistochemistry | 2 | 2017 | 2275 | 0.11 | Why? |
| Open Reading Frames | 1 | 2018 | 1898 | 0.11 | Why? |
| Animals | 14 | 2021 | 78931 | 0.11 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.10 | Why? |
| Safety | 1 | 2018 | 1583 | 0.10 | Why? |
| Drug Design | 2 | 2021 | 2627 | 0.10 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Bronchi | 1 | 2017 | 1048 | 0.10 | Why? |
| Adult | 15 | 2021 | 244371 | 0.10 | Why? |
| Peptide Fragments | 2 | 2020 | 2075 | 0.10 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.10 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.10 | Why? |
| Drug-Eluting Stents | 1 | 2016 | 562 | 0.10 | Why? |
| Lung | 7 | 2021 | 31049 | 0.10 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.10 | Why? |
| Trimetazidine | 1 | 2008 | 5 | 0.10 | Why? |
| Phylogeny | 2 | 2018 | 13341 | 0.09 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.09 | Why? |
| Cell Line, Tumor | 4 | 2018 | 3608 | 0.09 | Why? |
| Aftercare | 1 | 2018 | 1637 | 0.09 | Why? |
| Sequence Analysis, RNA | 1 | 2018 | 2290 | 0.09 | Why? |
| Cell Differentiation | 1 | 2015 | 1338 | 0.09 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Acute Lung Injury | 1 | 2017 | 904 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Medicine, Chinese Traditional | 1 | 2021 | 2255 | 0.09 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
| Acute Disease | 2 | 2018 | 6029 | 0.09 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.09 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.08 | Why? |
| Dyspnea | 2 | 2018 | 3847 | 0.08 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.08 | Why? |
| Survival Analysis | 2 | 2017 | 7592 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2021 | 7220 | 0.08 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.08 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.08 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.08 | Why? |
| Databases, Factual | 1 | 2021 | 6248 | 0.08 | Why? |
| Arthritis, Rheumatoid | 1 | 2019 | 2043 | 0.07 | Why? |
| Receptors, Adrenergic, beta-3 | 1 | 2004 | 10 | 0.07 | Why? |
| Lymphocyte Activation | 1 | 2015 | 2742 | 0.07 | Why? |
| Interferon-beta | 2 | 2021 | 979 | 0.07 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.07 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.07 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.07 | Why? |
| Mice | 6 | 2021 | 21357 | 0.07 | Why? |
| RNA, Messenger | 2 | 2017 | 5131 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Adrenergic beta-Agonists | 1 | 2004 | 93 | 0.07 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.07 | Why? |
| Energy Metabolism | 1 | 2008 | 451 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Cell Survival | 2 | 2021 | 1581 | 0.06 | Why? |
| Liver | 1 | 2018 | 4007 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Inflammation Mediators | 1 | 2015 | 2654 | 0.06 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2017 | 3388 | 0.06 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| A549 Cells | 2 | 2021 | 2066 | 0.06 | Why? |
| Molecular Structure | 2 | 2019 | 1539 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.06 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
| Mice, Inbred BALB C | 3 | 2018 | 5814 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.06 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.06 | Why? |
| Acute Coronary Syndrome | 1 | 2016 | 2107 | 0.06 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.06 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.06 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.06 | Why? |
| Structure-Activity Relationship | 2 | 2019 | 2219 | 0.06 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.05 | Why? |
| Infant | 2 | 2021 | 30274 | 0.05 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| Treatment Outcome | 5 | 2018 | 51732 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Marketing of Health Services | 1 | 2020 | 68 | 0.05 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2018 | 4273 | 0.05 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.05 | Why? |
| Mice, Inbred DBA | 1 | 2019 | 56 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2016 | 3051 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Cytokines | 3 | 2018 | 15010 | 0.05 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.05 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.05 | Why? |
| G2 Phase Cell Cycle Checkpoints | 1 | 2018 | 25 | 0.05 | Why? |
| Gene Deletion | 1 | 2021 | 430 | 0.05 | Why? |
| Biomarkers | 3 | 2020 | 23361 | 0.05 | Why? |
| Proline | 1 | 2021 | 345 | 0.05 | Why? |
| Peak Expiratory Flow Rate | 1 | 2018 | 64 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2017 | 6 | 0.05 | Why? |
| RNA Polymerase II | 1 | 2017 | 29 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Milk Thistle | 1 | 2017 | 4 | 0.04 | Why? |
| Acetyltransferases | 1 | 2017 | 30 | 0.04 | Why? |
| Transplantation, Heterologous | 1 | 2018 | 77 | 0.04 | Why? |
| Enhancer Elements, Genetic | 1 | 2017 | 48 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Mice, Inbred NOD | 1 | 2017 | 134 | 0.04 | Why? |
| NIH 3T3 Cells | 1 | 2017 | 147 | 0.04 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.04 | Why? |
| Neoplasms, Experimental | 1 | 2017 | 67 | 0.04 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2017 | 138 | 0.04 | Why? |
| Albuterol | 1 | 2018 | 105 | 0.04 | Why? |
| Mice, SCID | 1 | 2017 | 225 | 0.04 | Why? |
| Collagen | 1 | 2019 | 222 | 0.04 | Why? |
| Thoracotomy | 1 | 2017 | 85 | 0.04 | Why? |
| Reverse Genetics | 1 | 2021 | 439 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.04 | Why? |
| Cytosine | 1 | 2017 | 92 | 0.04 | Why? |
| Chromatin | 1 | 2017 | 107 | 0.04 | Why? |
| Oligopeptides | 1 | 2021 | 576 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Chemokine CXCL10 | 1 | 2021 | 565 | 0.04 | Why? |
| Plant Leaves | 1 | 2017 | 233 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 97 | 0.04 | Why? |
| Foundations | 1 | 2017 | 88 | 0.04 | Why? |
| Efficiency, Organizational | 1 | 2020 | 482 | 0.04 | Why? |
| Peroxidase | 1 | 2017 | 207 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 8811 | 0.04 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.04 | Why? |
| Geography, Medical | 1 | 2018 | 537 | 0.04 | Why? |
| Proof of Concept Study | 1 | 2018 | 696 | 0.04 | Why? |
| Metabolic Networks and Pathways | 1 | 2017 | 285 | 0.04 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.04 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Virus Shedding | 2 | 2021 | 5834 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2020 | 1262 | 0.03 | Why? |
| Anti-Bacterial Agents | 1 | 2016 | 10083 | 0.03 | Why? |
| Cardiovascular Agents | 1 | 2020 | 663 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Radiologists | 1 | 2020 | 873 | 0.03 | Why? |
| Vasodilator Agents | 1 | 2017 | 344 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2017 | 823 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Atrial Fibrillation | 1 | 2008 | 2320 | 0.03 | Why? |
| Absorbable Implants | 1 | 2016 | 191 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Datasets as Topic | 1 | 2020 | 1404 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Nucleic Acids | 1 | 2017 | 435 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.03 | Why? |
| Molecular Docking Simulation | 2 | 2019 | 6902 | 0.03 | Why? |
| Bronchodilator Agents | 1 | 2018 | 444 | 0.03 | Why? |
| Base Sequence | 1 | 2021 | 3581 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.03 | Why? |
| Cooperative Behavior | 1 | 2020 | 1216 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2018 | 1182 | 0.03 | Why? |
| Neoplasms | 2 | 2018 | 17251 | 0.03 | Why? |
| Polymers | 1 | 2016 | 507 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.03 | Why? |
| Colchicine | 1 | 2018 | 730 | 0.03 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.03 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.03 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Drug Discovery | 1 | 2021 | 3092 | 0.02 | Why? |
| Cardiac Pacing, Artificial | 1 | 2008 | 160 | 0.02 | Why? |
| Urban Population | 1 | 2017 | 2000 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Plant Extracts | 1 | 2017 | 1514 | 0.02 | Why? |
| Binding Sites | 1 | 2018 | 6201 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| In Situ Nick-End Labeling | 1 | 2004 | 39 | 0.02 | Why? |
| Mobile Applications | 1 | 2020 | 3032 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| Computer Simulation | 1 | 2018 | 4982 | 0.02 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.02 | Why? |
| Rats, Wistar | 1 | 2004 | 621 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Blotting, Western | 1 | 2004 | 863 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Dogs | 1 | 2008 | 2529 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Gene Expression | 1 | 2004 | 3332 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 13720 | 0.00 | Why? |